Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study
2017
Background: Level I evidence supports the use of sorafenib in patients with Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma, where heterogen
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
38
References
14
Citations
NaN
KQI